Neuronetics (STIM) announced President and CEO Keith Sullivan will step down effective March 23 and retire March 31 after more than five years in the role. This routine leadership transition at the Malvern, PA medical technology company is largely procedural and likely has limited immediate financial impact, though it may cause modest short-term stock volatility.
Neuronetics (STIM) announced President and CEO Keith Sullivan will step down effective March 23 and retire March 31 after more than five years in the role. This routine leadership transition at the Malvern, PA medical technology company is largely procedural and likely has limited immediate financial impact, though it may cause modest short-term stock volatility.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
